MedPath

A dermatological study to evaluate hair thickening spray (Containing Bhringraj and Shikakai) on healthy volunteers

Not Applicable
Active, not recruiting
Conditions
The objective of this study is to evaluate the efficacy of hair thickening spray (bhringraj and shikakai) on healthy human subjects.
Registration Number
CTRI/2022/05/042565
Lead Sponsor
Mountain Valley Springs India Pvt Ltd
Brief Summary

It is a single centre, prospective, open label, non-comparative study to evaluate the efficacy of Hair Thickening Spray (Bhringraj and shikakai) for hair growth, volume and hair thickness in healthy volunteers. This study will be conducted in compliance with applicable national regulations for Post Marketing Surveillance of cosmetic product with the aim of identifying or quantifying safety hazards relating to an authorized cosmetic product and is aligned with various guidelines and recommendations for guideline on PMS practices for cosmetic products.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) Indian Male/Female subjects.
  • Hair & scalp is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar etc) Between 18 to 65 years of age, with normal Hair condition.
  • Written informed consent signed by the subject in line with applicable regulation of country.
Exclusion Criteria
  • Having refused to give her consent by not signing the consent form.
  • Taking part in another study liable to interfere with this study.
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis).
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
  • Having cutaneous hypersensitivity.
  • Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only hair and scalp cleaned with water is accepted).

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation will include assessment of local adverse events of redness, itching, rashes and burning sensations and any other local side effect and will be categorized non serious (based on severity grades, patterns, and causality) and serious adverse events. There will be two types of assessment, subject self-assessment, and dermatological evaluation by study investigatorSubjects will assessed at 30 minutes, 15 days and 30 days after test product application
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Qaaf Healthcare International

🇮🇳

South, DELHI, India

Qaaf Healthcare International
🇮🇳South, DELHI, India
Dr Esha Roy
Principal investigator
9254425442
esharoy86@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.